Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.
Status:
Completed
Trial end date:
2018-11-11
Target enrollment:
Participant gender:
Summary
A phase I trial is being conducted in patients with inoperable locally advanced NSCLC to
treat with a combination of Conventional Fractionated Radiotherapy (CFRT) on the mediastinal
lymph nodes and Stereotactic Ablative Radiotherapy (SABR)on the primary tumor with concurrent
chemotherapy. It is hypothesized that this will lead to an increase of local control and
overall survival